کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1392034 1501101 2016 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Novel spiropyrazolone antitumor scaffold with potent activity: Design, synthesis and structure–activity relationship
ترجمه فارسی عنوان
داربست ضد اسپرمی اسپیرپروپرایازولون با فعالیت شدید: رابطه فعالیت، طراحی، ترکیب و ساختار
کلمات کلیدی
اسپیروپیراازولون، ضد تومور، آپوپتوز سلول سرطانی، رابطه ساختار-فعالیت
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آلی
چکیده انگلیسی


• Inspired by a novel spiropyrazolone antitumor scaffold, a series of derivatives were designed, synthesized and assayed.
• Most spiropyrazolone derivatives showed good in vitro antitumor activity with a broad spectrum.
• Compound 5k showed good antitumor activity and could effectively induce cancer cell apoptosis.

Phenotypic screening of high quality compound library is an effective strategy to discover novel bioactive molecules. Previously, we developed the divergent organocatalytic cascade approach to efficiently construct a focused library with scaffold diversity and successfully identified a novel spiropyrazolone antitumor scaffold. Herein, a series of spiropyrazolone derivatives were designed, synthesized and assayed. Most of them showed good in vitro antitumor activity with a broad spectrum. Preliminary structure–activity relationship for the substitutions and the stereo configuration were obtained. Compound 5k showed good antitumor activity and could effectively induce cancer cell apoptosis, which represents a good starting point for the development of novel antitumor agents.

Inspired by a novel spiropyrazolone antitumor scaffold, a series of spiropyrazolone derivatives were designed, synthesized and assayed for antitumor activity. Compound 5k showed good antitumor activity and could effectively induce cancer cell apoptosis.Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Medicinal Chemistry - Volume 115, 10 June 2016, Pages 141–147
نویسندگان
, , , , , , , , , , ,